Zoledronic-Acid-Induced Circulating Level Modifications of Angiogenic Factors, Metalloproteinases and Proinflammatory Cytokines in Metastatic Breast Cancer PatientsG. Ferretti, F. Cognetti, Elisabetta Trento et al.|Oncology|2005Cited by 133
Clinical Evaluation of the Use of Exemestane as Further Hormonal Therapy after Nonsteroidal Aromatase Inhibitors in Postmenopausal Metastatic Breast Cancer PatientsPaolo Carlini, Francesco Cognetti, Andrea Michelotti et al.|Cancer Investigation|2007Cited by 36
Pegylated liposomal doxorubicin in combination with gemcitabine: a phase II study in anthracycline-naïve and anthracycline pretreated metastatic breast cancer patientsAlessandra Fabi, F. Cognetti, G. Ferretti et al.|Cancer Chemotherapy and Pharmacology|2005Cited by 20
PANHER study: a 20-year treatment outcome analysis from a multicentre observational study of HER2-positive advanced breast cancer patients from the real-world settingLaura Pizzuti, Nicola Tinari, Eriseld Krasniqi et al.|Therapeutic Advances in Medical Oncology|2021Cited by 10
Can HER2 overexpression predict response to pegylated liposomal doxorubicin in metastatic breast cancer patients?Alessandra Fabi, F. Cognetti, G. Ferretti et al.|Annals of Oncology|2005Cited by 4